Literature DB >> 23747184

Distinguishing characteristics of urothelial carcinoma in kidney transplant recipients between China and Western countries.

G M Liu1, Q Fang, H S Ma, G Sun, X C Wang.   

Abstract

OBJECTIVE: To identify significant distinctive characteristics of urothelial carcinoma (UC) in kidney transplant recipients between China and Western countries and investigate probable tumor screening and treatment factors contributing to these differences.
METHODS: Renal transplant recipients from 1998 to 2011 in our institution diagnosed with UC were included in this study. Our data on tumor incidence, clinical characteristics, and outcomes were compared with literature reports.
RESULTS: Among 2572 renal transplant recipients identified, 24 (0.93%) experienced UC, including 10 men and 14 women of overall mean age of 49.3 ± 11.6 years at transplantation and 53.5 ± 9.5 years at tumor detection. The Chinese traditional herbal intake mainly focused on 2 preparations: Aristolochic acid and rhubarb (the latter was mainly used in patients with chronic renal impairment) in 20 people. There were 21 (87.5%) cases of upper (UTUC) 5 cases of bilateral, and 13 cases of multifocal urinary tract urothelial carcinoma. Four subjects died owing to tumor progression at 4-63 months postoperatively.
CONCLUSIONS: UC in renal transplant recipients shared notable characteristics in China with widespread herb intake: UTUC predominance; multifocal and bilateral organ involvement; high rates of recurrence, progression, and dissemination, in contrast with bladder tumor dominance in Western countries. As a consequence, we suggest that bilateral nephroureterectomy should be performed prophylactically in high-risk patients, especially those with a long history of Chinese herb intake. The relationship of rhubarb consumption to UC in renal transplant recipients should be noted and evaluated.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23747184     DOI: 10.1016/j.transproceed.2012.10.035

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

1.  Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in Taiwan.

Authors:  Chia-Shen Chien; Hao Lun Luo; Chou Shu Ling; Po-Hui Chiang; Yen-Ta Chen; Yuan Tso Cheng
Journal:  Int Urol Nephrol       Date:  2016-05-18       Impact factor: 2.370

2.  Chemotherapy for urothelial carcinoma in renal transplantation patients: Initial results from a single center.

Authors:  Yichen Zhu; Jing Xiao; Yuwen Guo; Jun Lin; Lei Zhang; Y E Tian
Journal:  Mol Clin Oncol       Date:  2015-07-30

Review 3.  Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.

Authors:  Li-Jen Wang; Shen-Yang Lee; Bin Tean Teh; Cheng-Keng Chuang; Joëlle Nortier
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.